In addition to the anti-diabetic effect of metformin, a growing number of studies have shown
that metformin has some exciting properties, such as anti-oxidative capabilities, anticancer …

Upon infection, mycobacteria, such as Mycobacterium tuberculosis (Mtb) and
nontuberculous mycobacteria (NTM), are recognized by host innate immune cells, triggering …

Background Metformin, the most widely administered diabetes drug, has been proposed as
a candidate adjunctive host-directed therapy for tuberculosis, but little is known about its …

Purpose To compile validation findings of diagnosis codes and related algorithms for health
outcomes of interest from National Health Insurance (NHI) or electronic medical records in …

Background Accumulating evidence suggested that the use of metformin had more benefits
for both prevention and treatment of tuberculosis (TB) than non-metformin use in patients …

Background Tuberculosis (TB) remains one of the infectious diseases with a leading cause
of death among adults worldwide. Metformin, a first-line medication for the treatment of type …

ABSTRACT Introduction: In 2018, an estimated 377,000 people developed multidrug-
resistant tuberculosis (MDR-TB), urging for new effective treatments. In the last years, it has …

Tuberculosis (TB) remains as the first cause of death among infectious diseases worldwide.
Global incidence of tuberculosis is in part coincident with incidence of type 2 diabetes (T2D) …

Human tuberculosis (TB) is primarily caused by Mycobacterium tuberculosis (Mtb) that
inhabits inside and amidst immune cells of the host with adapted physiology to regulate …

Diabetes mellitus characterized by hyperglycaemia presents an array of comorbidities such
as cardiovascular and renal failure, dyslipidemia, and cognitive impairments. Populations …